Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sirolimus for Treating COVID-19 Infection

NCT04461340 is registered in ClinicalTrials.gov with Alexandria University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04461340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sirolimus for Treating COVID-19 Infection
Lead sponsor
Alexandria University
Phase
Phase 2
Overall status
Unknown status
Start date
August 15, 2020
Completion date
November 30, 2020
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19